Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
about
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyRecent advances in understanding idiopathic pulmonary fibrosisPharmacological management of IPFNew perspectives on management of idiopathic pulmonary fibrosisPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesLung transplantation in IIP: A reviewIdiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural historyUnder-recognised co-morbidities in idiopathic pulmonary fibrosis: A reviewManaging comorbidities in idiopathic pulmonary fibrosisSmoking-related interstitial lung diseaseIdiopathic Pulmonary Fibrosis: Treatment and PrognosisUpdate on diagnosis and treatment of idiopathic pulmonary fibrosisUpdate on therapeutic management of idiopathic pulmonary fibrosisPrecision Medicine: The New Frontier in Idiopathic Pulmonary FibrosisIdiopathic pulmonary fibrosis in East Asian.Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.H2 receptor antagonists and right ventricular morphology: the MESA right ventricle studyDiffuse aspiration bronchiolitis: analysis of 20 consecutive patients.Role of bronchoalveolar lavage in the diagnosis of acute exacerbations of idiopathic pulmonary fibrosis: a retrospective study.Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosisIdiopathic fibrotic lung disease at a university hospital setting: management and prognostic factorsImpact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary FibrosisGastroesophageal reflux and idiopathic pulmonary fibrosis: A long term relationship.A bundled care approach to patients with idiopathic pulmonary fibrosis improves transplant-free survival.Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis.Acute exacerbations in patients with idiopathic pulmonary fibrosis.Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.Epidemiology of idiopathic pulmonary fibrosis.Recommendations for the management of idiopathic pulmonary fibrosis in South Africa: a position statement of the South African Thoracic SocietyTherapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model.Diagnosis and management of interstitial lung disease.Epigenetics in idiopathic pulmonary fibrosis.Gastroesophageal reflux disease and non-digestive tract diseases.Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapiesReflux in idiopathic pulmonary fibrosis.Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
P2860
Q26738458-9194020B-C2D5-43A3-8FC9-F8C37BB603E2Q26745905-CF8871B8-4650-467B-940F-983C5DF422B6Q26748808-954DCC97-FDB9-4464-AAB5-54D8A7D7A4D3Q26765586-EB386017-E604-4E99-BBB7-967D5697D1F8Q26771309-1F0EC37B-4BC1-4321-A669-3E65C647176FQ26774870-4D24C133-498A-47DF-AF77-CBFB25F141B0Q26776473-646C7BFB-A66B-4BFC-8B55-CB33CEDE48A8Q26781255-B3CD17AD-B251-45F0-8DEA-F3F5425E261FQ26785617-BFDF875A-3A44-4167-9A46-4AC0588D1273Q27027779-F2D34161-4DD2-4742-9400-8FE2E2A482A9Q28073641-AFA3E633-93A0-4A63-BF5A-24139E7DF879Q28083702-B3997D46-A14B-4E2A-9809-31C60D314FBFQ28083944-CCD1B7A4-42EE-4734-B8BB-A72C26CF6EA0Q33714064-F6787B2E-1362-46D0-97B0-02CAC2B2E177Q33747908-451A4558-66C0-41DE-A833-F495CAD8D2E3Q33749957-92AEEF82-B9C3-4805-90F9-851E298CF0E8Q34432217-76F51076-DD28-4700-A4C7-63D00AFA56B0Q34984706-F0783F90-A85B-4345-81C6-DBFADEA8DA4FQ35597815-81961B65-B44E-4319-9D6F-499467047765Q35687459-D9CF45FC-43A6-4236-8A76-97CAA64815F9Q35908085-53591E65-942B-4240-9E73-05302BD8E9E8Q36239398-CC79FCF4-CA32-44AC-B475-910BD6055D26Q36739149-138CC16C-EFFA-4872-9F9F-82BFF86F657AQ36766733-0C824AF4-202F-4157-9EC9-1157020D0980Q36934514-8CB74830-0780-4F56-B5A1-3E73FE8DC46BQ37013159-C9155149-5049-4A6B-B9F7-DD68A82E2F23Q37058960-2125BAA0-16D5-4463-B3D3-04EC74284EE8Q37152742-A6615B8B-30D8-45FC-9A9B-11537E04F6D7Q37237739-A07F253E-C02B-4848-BDEA-1AD33813D414Q37359126-28C0A651-22C2-4CD6-9026-3C3FB764377BQ37581185-85F18FA9-FBA9-4F5B-A134-CD1D285E4525Q37607150-B32493BC-A0CB-4D3D-9923-53143CE8B0F9Q38288028-6DE1FA14-EF82-4649-A5ED-D0358F659D23Q38346940-5580DF51-4D13-44AF-9797-13BE50C1B846Q38349428-47FB75F5-A64B-4043-A506-96E29D1AFB61Q38352111-2E8C6815-C9FF-4972-876C-9C115AFF40BFQ38448525-F0772EAA-AB36-48B9-B558-C3EFC9C16118Q38576444-F3C6109B-FC03-4973-B7B5-2369ED931FBBQ38616538-FDC9B4D8-6963-4EE6-8D86-FC0380B19BBEQ38630663-E03C0851-7A08-49D8-9A31-72481F7A9E76
P2860
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Anti-acid treatment and diseas ...... randomised controlled trials.
@ast
Anti-acid treatment and diseas ...... randomised controlled trials.
@en
type
label
Anti-acid treatment and diseas ...... randomised controlled trials.
@ast
Anti-acid treatment and diseas ...... randomised controlled trials.
@en
prefLabel
Anti-acid treatment and diseas ...... randomised controlled trials.
@ast
Anti-acid treatment and diseas ...... randomised controlled trials.
@en
P2093
P2860
P1476
Anti-acid treatment and diseas ...... randomised controlled trials.
@en
P2093
Fernando J Martinez
Ganesh Raghu
Harold R Collard
IPFnet Investigators
Joyce S Lee
Rhonda S Roberts
P2860
P304
P356
10.1016/S2213-2600(13)70105-X
P577
2013-06-14T00:00:00Z